1. Inotani S, Taniguchi Y, Nakamura K, Nishikawa H, Matsumoto T, Horino T, Fujimoto S, Sano S, Yanagita M, Terada Y：Knockout of Zeb2 ameliorates progression of renal tubulointerstitial fibrosis in a mouse model of renal ischemia-reperfusion injury.
Nephrol Dial Transplant, 37(3):454-468, 2022
2. Hamada T, Morita A, Suga H, Boki H, Fujimura T, Hirai Y, Shimauchi T, Tateishi C, Kiyohara E, Muto I, Nakajima H, Abe R, Fujii K, Nishigori C, Nakano E, Yonekura K, Funakoshi T, Amano M, Miyagaki T, Makita N, Manaka K, Shimoyama Y, Sugaya M.：Safety and efficacy of bexarotene for Japanese patients with cutaneous T-cell lymphoma: Real-world experience from post-marketing surveillance.
J Dermatol, 49(2):253-262, 2022
3. Horino T, Inotani S, Nakajima H, Ohnishi H, Komori M, Terada Y：Calcinosis and acro-osteolysis in systemic sclerosis.
QJM, 115(2):113-114, 2022
4. Aoki N，Nakajima H, Nakajima K, Sano S：Severe irritant contact dermatitis from olanexidine gluconate and subsequent skin sensitization.
Contact dermatitis, 86(3):234-236, 2022
5. Nakajima K, Suzuki H, Yamamoto M, Yamamoto T, Kawai T, Nakabayashi K, Hata K, Kosaki K, Nakajima H, Sano S, Kubo A：A familial case of periodontal Ehlers-Danlos syndrome lacking skin extensibility and joint hypermobility with a missense mutation in C1R.
J Dermatol， 49(7)：714-718, 2022
6. Nakajima K, Nakajima H, Araki M, Fujieda M, Sano S：Dyskeratosis, a characteristic histopathological feature, seen in a patient with systemic juvenile idiopathic arthritis．
7. Kase M, Fujita Y, Ota A, Shimizu S, Itoi-Ochi S, Sano S：Loss of epidermal Langerhans cells in psoriasiform lesions of de novo induced or worsened pre-existing psoriasis following uses of immune checkpoint inhibitors．
J Dermatol, 49(9):916-920, 2022
8. Oguro T, Nakajima K, Aoki N, Yamamoto M, Sano S：A case of psoriasiform drug eruption caused by temozolomide.
9. Morita A, Nishikawa K, Yamada F, Yamanaka K, Nakajima H, Ohtsuki M：Safety, efficacy, and drug survival of the infliximab biosimilar CT-P13 in post-marketing surveillance of Japanese patients with psoriasis.
